Lyell Immunopharma, Inc. (LYEL) vs Niagen Bioscience, Inc. (NAGE)

• Lyell Immunopharma, Inc. LYEL 8.12 ▼ −0.85%
• Niagen Bioscience, Inc. NAGE 2.49 ▼ −3.49%

Lyell Immunopharma, Inc. and Niagen Bioscience, Inc. are both Biotechnology companies. Lyell Immunopharma, Inc. and Niagen Bioscience, Inc. are of similar size ($204.2M and $200.7M). Lyell Immunopharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 12.5×. Niagen Bioscience, Inc. grew revenue faster over the last twelve months: 11.0% against −55.0%. Niagen Bioscience, Inc. has the higher net margin (12.4% vs −920,285.2%) and the higher return on invested capital (42.0% vs −539.5%). Across the 18 metrics below, Niagen Bioscience, Inc. leads on 14 and Lyell Immunopharma, Inc. on 4.